Natural ceramide is unable to escape the lysosome, in contrast to a fluorescent analogue

被引:62
作者
Chatelut, M
Leruth, M
Harzer, K
Dagan, A
Marchesini, S
Gatt, S
Salvayre, R
Courtoy, P
Levade, T
机构
[1] CHU Rangueil, Inst Louis Bugnard, Biochim Lab, INSERM,U466, F-31403 Toulouse 4, France
[2] Catholic Univ Louvain, ICP, Cell Biol Unit, Brussels, Belgium
[3] Max Planck Inst Hirnforsch, Neurochem Lab, Tubingen, Germany
[4] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91010 Jerusalem, Israel
[5] Univ Brescia, Dept Biomed Sci & Technol, Brescia, Italy
关键词
ceramide; lysosome; Farber disease; sphingomyelin; sulfatide;
D O I
10.1016/S0014-5793(98)00325-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since the generation upon cell stimulation of the second messenger ceramide has been reported to occur in an endosomal/lysosomal compartment, we investigated whether ceramide formed in the lysosomes can escape this compartment. The metabolic fate of radiolabelled ceramide produced by intralysosomal hydrolysis of LDL-associated [ceramide-H-3]sphingomyelin or [stearoyl-1-C-14]sulfatide was examined in fibroblasts from control individuals and a patient with inborn lysosomal ceramidase deficiency (Farber disease), The behavior of this radioactive ceramide was compared to that of a fluorescent (lissamine-rhodaminyl) ceramide analogue deriving from sulfatide degradation. While in Farber cells the natural, radiolabelled ceramide remained completely undegraded and accumulated in the lysosomes, the fluorescent derivative was rapidly converted to sphingomyelin. These findings strongly suggest that, in contrast to fluorescent derivatives, endogenous long-chain ceramide is unable to exit from lysosomes, therefore making the lysosomal ceramide unlikely to be a biomodulatory molecule. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:102 / 106
页数:5
相关论文
共 33 条
[1]  
AGMON V, 1993, CLIN CHIM ACTA, V218, P139
[2]   Comparative study of the metabolic pools of sphingomyelin and phosphatidylcholine sensitive to tumor necrosis factor [J].
Andrieu, N ;
Salvayre, R ;
Levade, T .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 236 (02) :738-745
[3]  
ANTES P, 1992, EUR J CELL BIOL, V59, P27
[4]   SPHINGOMYELINS IN BILAYERS AND BIOLOGICAL-MEMBRANES [J].
BARENHOLZ, Y ;
THOMPSON, TE .
BIOCHIMICA ET BIOPHYSICA ACTA, 1980, 604 (02) :129-158
[5]   A simple method for screening for Farber disease on cultured skin fibroblasts [J].
Chatelut, M ;
Feunteun, J ;
Harzer, K ;
Fensom, AH ;
Basile, JP ;
Salvayre, R ;
Levade, T .
CLINICA CHIMICA ACTA, 1996, 245 (01) :61-71
[6]   Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies [J].
Chatelut, M ;
Harzer, K ;
Christomanou, H ;
Feunteun, J ;
Pieraggi, MT ;
Paton, BC ;
Kishimoto, Y ;
OBrien, JS ;
Basile, JP ;
Thiers, JC ;
Salvayre, R ;
Levade, T .
CLINICA CHIMICA ACTA, 1997, 262 (1-2) :61-76
[7]   ROLE OF LYSOSOMAL ACID CERAMIDASE IN THE METABOLISM OF CERAMIDE IN HUMAN-SKIN FIBROBLASTS [J].
CHEN, WW ;
MOSER, AB ;
MOSER, HW .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1981, 208 (02) :444-455
[8]   RELATIONS BETWEEN PLASMA-MEMBRANE AND LYSOSOMAL MEMBRANE .1. FATE OF COVALENTLY LABELED PLASMA-MEMBRANE PROTEIN [J].
DRAYE, JP ;
QUINTART, J ;
COURTOY, PJ ;
BAUDHUIN, P .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1987, 170 (1-2) :395-403
[9]  
FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650
[10]   Lipid biochemistry: Functions of glycerolipids and sphingolipids in cellular signaling [J].
Ghosh, S ;
Strum, JC ;
Bell, RM .
FASEB JOURNAL, 1997, 11 (01) :45-50